fashion -WSS

fashion

author：Wikipedia 2025-09-29 23:03:52 - browse：9

FDA's Peter Marks talks with STAT's Adam Feuerstein — Peter Marks, the FDA's top regulator of gene therapies (right), speaks with STAT's Adam Feuerstein in San Francisco. Sarah Gonzalez/Peopletography for STAT

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

To be clear, Marks declined to comment specifically about the ongoing FDA review of Elevidys. I tried. However, Marks described a “hypothetical case” in the context of my Sarepta questions that clearly suggested the failure of an Elevidys confirmatory study in October didn’t bother him all that much.

“Hypothetically, if you had a product that used an aggregate scale and all of the components of that aggregate scale looked pretty good, or nearly all of them look pretty good, but the aggregate, for various reasons, didn’t come out perfectly. We approved products based on that,” Marks told me.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： FDA approves first blood sugar monitor without finger pricks

WSS

Adopting new red light myopia treatments may be short

4 missing after record

Doctors have an ethical obligation to be advocates

Padmanee Sharma of MD Anderson at center of lawsuit over credit

A single Democrat is willing to weaken Medicare negotiation power

Texas Medical Board asked to define abortion emergency exception

entertainment

fashion

leisure time

Guidelines to prevent youth baseball injuries need more muscle

Where does female orgasm come from? Scientists think they know

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Updated Covid vaccine has 54% effectiveness, new study suggests

At least 13 dead in Texas as scorching temps continue

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Affirmative action in medical school literally saved lives

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

In age of alternative facts, a scholarly course on calling out crap

New requirements coming in 2024 for Americans traveling to Europe

leisure time

Transgender women dream of pregnancy via uterus transplants

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Updated Covid vaccine has 54% effectiveness, new study suggests

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Medicare Advantage plans can’t deny care with AI, CMS warns

hotspot

leisure time

Wikipedia

hotspot